Candidal Vulvovaginitis (ICD-10 Code: B37.3)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Candidal Vulvovaginitis (ICD-10 Code: B37.3) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 2/3

NCT06835361

Efficacy and Safety of Clotrimazole+Lactulose Vaginal Suppositories Vs. Clotrimazole Monotherapy in Adult Women with Can…

This study aims to compare the efficacy and safety of the combination drug Clotrimazole+Lactulose with the monocomponent product Canesten® (clotrimazole) in adu…

Belarus264 participantsStarted 2024-02-29

Treatment: Clotrimazole+Lactulose., Canesten (Clotrimazole)

Candidal Vulvovaginitis (ICD-10 Code: B37.3)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Efficacy and Safety of Clotrimazole+Lactulose Vaginal Suppositories Vs. Clotrimazole Monotherapy in Adult Women with Can…

All recent trials (1 shown)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Efficacy and Safety of Clotrimazole+Lactulose Vaginal Suppositories Vs. Clotrimazole Monotherapy in Adult Women with Can…

All recent trials (1 shown)